ANTI-ANGIOGENIC ACTIVITY OF GENISTEIN IN ORAL CARCINOGENESIS

구강암 발암과정에서 genistein의 혈관형성 억제에 관한 연구

  • Song, Seung-Il (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University) ;
  • Kim, Myung-Jin (Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University)
  • 송승일 (서울대학교 치과대학 구강악안면외과학교실) ;
  • 김명진 (서울대학교 치과대학 구강악안면외과학교실)
  • Published : 2004.10.30

Abstract

Angiogenesis inhibition is major concern to cancer chemotherapy and many studies about compound inhibiting angiogenesis is in progression. The long-known preventive effect of plant-based diet on tumorigenesis and other chronic diseases is well documented. Especially soy extract, genistein, is known to be potent angiogenesis inhibitor and prevent development and progression of tumor. In the present study, the effect of angiogenesis on tumorigenesis and chemopreventive effect of genistein by angiogenesis inhibition in hamster buccal pouch oral carcinigenesis model induced by 7.12-dimethylbenza(a)nthracene (DMBA) was studied. Forty eight Syrian Golden young adult hamsters (150-200 gm) were divided into two groups. In control group, 0.5% DMBA in heavy mineral oil was applied to hamster buccal pouch three times a week and in experimental group, 0.1 mg of genistein is administered orally everyday in addition to DMBA application. The animals were euthanized from 2 weeks to 16 weeks with interval of 2 week. H&E staining and immunohistochemistry was performed to evaluate microvessel density by using factor VIII-related antigen and avidin-biotin technique. Microvessels per area was quantified and compared between control and experimental group statistically. The results were as follows. 1. Microvessel density was increased time dependently in both groups and especially the increase was significant from 12 weeks to 16 weeks. 2. When comparing both group, the experimental group showed significantly low microvessel density than control group in 12 weeks (p=0.043), 14 weeks (p=0.050), 16 weeks (p=0.037). Based on these results, it was concluded that genistein influenced oral carcinogenesis by angiogenesis inhibition.

Keywords

References

  1. Klagsbrum M, Folkman, J: Peptide Growth Factors and Their Receptors II. Angiogenesis. Berlin, Springer Verlag, 1990;549-586
  2. Denekamp J: Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev 1990;9:267-282 https://doi.org/10.1007/BF00046365
  3. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985;43: 175-203 https://doi.org/10.1016/S0065-230X(08)60946-X
  4. Folkman J, Cotran RS: Relationship of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976;16:207-248
  5. Adlercreutz H: Western diet and western disease: some hormonal and biochemical mechanism and associations. Scan J Clin Lab Invest 1990;50(suppl. 210):3-23 https://doi.org/10.1080/00365519009085798
  6. Miller AB: Diet and cancer: a review. Rev Oncol 1990;3:87-95
  7. Rose DP, Boyar AP, Wydner EL: International comparison of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita for consumption. Cancer 1986;58:2263-2271
  8. Kolonel LN: Variability and diet and its relationship to risk im ethnic and migrant groups. Basic Life Sci 1988;43:129-135
  9. Lee HP, Courley L, Duffy SW: Dietary effects on breast cancer risk in Singapore. Lancet 1991;337:1197-1200 https://doi.org/10.1016/0140-6736(91)92867-2
  10. Fortis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angigenesis. Proc Natl Acad Sci 1993;90:2690-2694 https://doi.org/10.1073/pnas.90.7.2690
  11. Fortis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L: Genistein, a diet-derived ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995; 25(suppl.):790S-797S
  12. Silvano B, Arthur KC: Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathol 1992;23:755-761 https://doi.org/10.1016/0046-8177(92)90344-3
  13. Andreas O, Petra K, Dagmar BT, Clemens T, Gerhard S: Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gyneclo Oncol 1996;63:204-209 https://doi.org/10.1006/gyno.1996.0307
  14. Gimbrone MA, Leapman S, Cotran RS, Folkman J: Tumor growth neovascularization: An experimental model using rabbit cornea. J Natl Cancer Inst 1974;52:413-427 https://doi.org/10.1093/jnci/52.2.413
  15. Rak JW, Hegman EJ, Lu C, Kerbel RS: Progressive loss of sensitivity to endothelial derived inhibitors expressed by lumen melanoma cells during disease progression. J Cell Physiol 1994; 59:245-255
  16. Moscanelli D, Gross J, Rifikin D: Angiogenic factors stimulate plasminogen activator and collagenase production by capillary endothelial cells. J Pathol 1993;70(suppl):388
  17. Hart IR, Saini A: Biology of tumor metastasis. Lancet 1992; 339:1453-1457 https://doi.org/10.1016/0140-6736(92)92039-I
  18. Solt DB, Shklar G: Rapid induction of $\gamma$-glutamyl transpeptidase - rich intraepithelial clones in 7,12-dimethylbenza(a)nthracene treated hamster buccal pouch. Cancer Res 1982;42:285-291
  19. Hussong JW, Polverni PJ, Solt DB: Resistent keratinocyte in 7,12- dimethylbenza(a)nthracene-initiated hamster buccal pouch epithelium. Carcinogenesis 1991;12:617-622 https://doi.org/10.1093/carcin/12.4.617
  20. Schwartz JL, Shklar G: Retinoid and carotenoid angiogenesis: a possible explanation for enhanced oral carcinogenesis. Nutr Cancer 1997;27:192-199 https://doi.org/10.1080/01635589709514524
  21. Schwartz JL, Shklar G: Glutathione inhibits experimental oral carcinogenesis, p53 expession and angiogenesis. Nutr Cancer 1996;26:229-236 https://doi.org/10.1080/01635589609514479
  22. Athanassios D, Holger M, Elisabeth S, Georg F, Alfonso CA, Fred G, Joachim T: Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathologic correlations. Gynecol Oncol 1997;67:27-33 https://doi.org/10.1006/gyno.1997.4835
  23. Moriyama S, Kumagai S, Kawashiri K, Kojima K: Immunohistochemical study of tumor angiogenesis in oral squamous cell carcinoma. Oral Oncol 1997;33:369-374 https://doi.org/10.1016/S1368-8375(97)00025-0
  24. Shitani S, Rafael A, Yoshimura Y: Immunohistochemical detection of microvessels in oral squamous cell carcinoma. Jpn J Oral Maxillofac Surg 1994;40:645-650 https://doi.org/10.5794/jjoms.40.645
  25. Smith-McCune KK, Weidner N: Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994;54:800-804
  26. Coward L: Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 1998;68(6 suppl): 1486S-1491S https://doi.org/10.1093/ajcn/68.6.1486S
  27. Lu LJ: Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 1998;68(6 suppl): 1500S-1504S https://doi.org/10.1093/ajcn/68.6.1500S
  28. Peterson G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 1995;25(3 suppl):784S-789S
  29. O’Shaughnessy JA: Chemoprevention of breast cancer. JAMA 1996;275:1349-1353 https://doi.org/10.1001/jama.275.17.1349
  30. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S: Genistein suppresses mammary cancer in rats. Carcinogenesis 1995;16:2833-2840 https://doi.org/10.1093/carcin/16.11.2833
  31. Shao ZM, Wu J, Shen ZZ, Barsky SH: Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 1998;58:4851-4857
  32. Moyad MA: Soy, disease prevention, and prostate cancer. Semin Urol Oncol 1999;7:97-102
  33. Evans DJ: Screening for prostate cancer: detecting and extirpating premetastatic tumors seems a legitimate objective. BMJ 1998;20:1903-1909
  34. Barnes S, Peterson TG, Coward L: Rationale for the use of genisteincontaining soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem 1995;22:181-187